{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:36:19Z","timestamp":1775500579586,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Sarcoidosis is an inflammatory disease characterized by granulomas, the etiology of which remains unclear. This study examines sarcoidosis-related mortality trends in the United States from 1999 to 2020, with a focus on disparities pertaining to patient sex, geographical location, and urbanization status.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We analyzed death certificate data from the CDC WONDER database, using ICD-10 code D86. Age-adjusted mortality rates (AAMR) per 1,000,000 people were calculated. Trends were analyzed using Joinpoint regression models to determine annual percentage changes (APC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 37,956 Sarcoidosis-related deaths were documented from 1999 to 2020 in the United States. The AAMR increased from 3.9 in 1999 to 6.4 in 2020. Significant mortality increases were observed from 1999\u20132001 and again from 2018\u20132020. Mortality rates were consistently higher among women compared to men. A significant difference in AAMR was observed across states, with highest mortality in the South region and lowest in the West region. Urbanization trends shifted from higher AAMR rates in metropolitan to non-metropolitan areas post-2018. Non-Hispanic Black individuals experienced the highest mortality rates throughout the study period.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study highlights significant racial and geographic disparities in sarcoidosis-related mortality. Women, Black patients, and those residing in non-metropolitan areas are at the highest risk for Sarcoidosis associated mortality. Targeted public health interventions are required to address these prevalent disparities.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0317237","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:01:48Z","timestamp":1736539308000},"page":"e0317237","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020"],"prefix":"10.1371","volume":"20","author":[{"given":"Fatima Ali","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9261-0400","authenticated-orcid":true,"given":"Areej","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-9734","authenticated-orcid":true,"given":"Farooq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohaib","family":"Tousif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urwah","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamea Bint","family":"Sahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-5942","authenticated-orcid":true,"given":"Sajjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-153X","authenticated-orcid":true,"given":"Mah I. Kan","family":"Changez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"pone.0317237.ref001","unstructured":"Sarcoidosis [Internet]. [cited 2024 Nov 4]. Available from: https:\/\/www.mountsinai.org\/health-library\/diseases-conditions\/sarcoidosis."},{"key":"pone.0317237.ref002","unstructured":"Sarcoidosis | sarcoidosis symptoms [Internet]. U.S. National Library of Medicine; [cited 2024 Nov 4]. Available from: https:\/\/medlineplus.gov\/sarcoidosis.html."},{"key":"pone.0317237.ref003","unstructured":"Sarcoidosis [Internet]. Mayo Foundation for Medical Education and Research; 2019 [cited 2024 Nov 4]. Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/sarcoidosis\/symptoms-causes\/syc-20350358."},{"key":"pone.0317237.ref004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999\u20132016","volume":"149","author":"GD Kearney","year":"2019","journal-title":"Respiratory Medicine."},{"key":"pone.0317237.ref005","unstructured":"Joinpoint trend analysis software [Internet]. [cited 2024 Nov 4]. Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"issue":"4","key":"pone.0317237.ref006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States, 1979\u20131991: An analysis of multiple-cause mortality data","volume":"100","author":"NM Gideon","year":"1996","journal-title":"The American Journal of Medicine"},{"issue":"11","key":"pone.0317237.ref007","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"JJ Swigris","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"8","key":"pone.0317237.ref008","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. patients with sarcoidosis","volume":"201","author":"LJ Harper","year":"2020","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"pone.0317237.ref009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdin.2022.07.006","article-title":"The prevalence and geographic distribution of sarcoidosis in the United States","volume":"9","author":"HH Nam","year":"2022","journal-title":"JAAD International"},{"issue":"7","key":"pone.0317237.ref010","article-title":"Trends and disparities in cardiovascular death in sarcoidosis: A population\u2010based retrospective study in the United States from 1999 to 2020","volume":"13","author":"MC Tan","year":"2024","journal-title":"Journal of the American Heart Association"},{"key":"pone.0317237.ref011","unstructured":"Rural Healthcare [Internet]. U.S. National Library of Medicine; [cited 2024 Nov 4]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576367\/."},{"key":"pone.0317237.ref012","unstructured":"Cromartie J. Rural America at a glance, 2018 edition [Internet]. [cited 2024 Nov 4]. Available from: https:\/\/www.ers.usda.gov\/publications\/pub-details\/?pubid=90555."},{"issue":"2","key":"pone.0317237.ref013","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"M Mirsaeidi","year":"2015","journal-title":"Chest"},{"issue":"12","key":"pone.0317237.ref014","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis","volume":"170","author":"LS Newman","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"pone.0317237.ref015","doi-asserted-by":"crossref","first-page":"l5553","DOI":"10.1136\/bmj.l5553","article-title":"New advances in the management of pulmonary sarcoidosis","author":"DA Culver","year":"2019","journal-title":"BMJ"},{"issue":"8","key":"pone.0317237.ref016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis\u2014scientific progress and clinical challenges","volume":"7","author":"ES Chen","year":"2011","journal-title":"Nature Reviews Rheumatology"},{"issue":"5","key":"pone.0317237.ref017","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00073012","article-title":"The pathogenesis of pulmonary fibrosis: A moving target","volume":"41","author":"WA Wuyts","year":"2012","journal-title":"European Respiratory Journal"},{"issue":"4","key":"pone.0317237.ref018","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.chest.2021.06.003","article-title":"Sarcoidosis","volume":"160","author":"LC Oliver","year":"2021","journal-title":"Chest"},{"issue":"9","key":"pone.0317237.ref019","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/diagnostics11091558","article-title":"Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis","volume":"11","author":"N Bernardinello","year":"2021","journal-title":"Diagnostics"},{"issue":"9","key":"pone.0317237.ref020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review","volume":"327","author":"JA Belperio","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"pone.0317237.ref021","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"M Drent","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0317237.ref022","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/07853890.2022.2063375","article-title":"Comorbidities of sarcoidosis","volume":"54","author":"C Tana","year":"2022","journal-title":"Annals of Medicine"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0346409","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:02:11Z","timestamp":1736539331000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317237"}},"subtitle":[],"editor":[{"given":"Amr Ehab","family":"El-Qushayri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317237","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}